Endothelial progenitor cell dysfunction in cardiovascular diseases: Role of reactive oxygen species and inflammation

Chih Pei Lin, Feng Yen Lin, Po Hsun Huang, Yuh Lien Chen, Wen Chi Chen, Huey Yi Chen, Yu Chuen Huang, Wen Ling Liao, Huey Chun Huang, Po Len Liu*, Yung Hsiang Chen

*此作品的通信作者

研究成果: Review article同行評審

78 引文 斯高帕斯(Scopus)

摘要

Endothelial progenitor cells (EPCs) move towards injured endothelium or inflamed tissues and incorporate into foci of neovascularisation, thereby improving blood flow and tissue repair. Patients with cardiovascular diseases have been shown to exhibit reduced EPC number and function. It has become increasingly apparent that these changes may be effected in response to enhanced oxidative stress, possibly as a result of systemic and localised inflammatory responses. The interplay between inflammation and oxidative stress affects the initiation, progression, and complications of cardiovascular diseases. Recent studies suggest that inflammation and oxidative stress modulate EPC bioactivity. Clinical medications with anti-inflammatory and antioxidant properties, such as statins, thiazolidinediones, angiotensin II receptor 1 blockers, and angiotensin-converting enzyme inhibitors, are currently administered to patients with cardiovascular diseases. These medications appear to exert beneficial effects on EPC biology. This review focuses on EPC biology and explores the links between oxidative stress, inflammation, and development of cardiovascular diseases.

原文English
文章編號845037
期刊BioMed Research International
2013
DOIs
出版狀態Published - 2013

指紋

深入研究「Endothelial progenitor cell dysfunction in cardiovascular diseases: Role of reactive oxygen species and inflammation」主題。共同形成了獨特的指紋。

引用此